Valuation : Amgen Inc.

Market Cap 239B 206B 193B 177B 330B 22,632B 333B 2,287B 891B 11,566B 899B 879B 37,249B P/E 2026 *
28x
P/E 2027 * 25.1x
Enterprise Value 281B 242B 227B 208B 388B 26,573B 391B 2,685B 1,046B 13,580B 1,056B 1,033B 43,735B EV / Sales 2026 *
7.22x
EV / Sales 2027 * 6.85x
Free-Float
99.77%
Yield 2026 *
2.28%
Yield 2027 * 2.41%
1 day+0.09%
1 week+1.56%
Current month+3.24%
1 month+17.14%
3 months+31.22%
6 months+17.72%
Current year+35.60%
1 week 426
Extreme 426
445.82
1 month 376.02
Extreme 376.02
447.03
Current year 318.21
Extreme 318.21
447.03
1 year 269.77
Extreme 269.77
447.03
3 years 248.38
Extreme 248.38
447.03
5 years 198.64
Extreme 198.64
447.03
10 years 133.64
Extreme 133.64
447.03
Manager TitleAgeSince
Chief Executive Officer 63 30/04/2012
Director of Finance/CFO 62 12/05/2010
Chief Tech/Sci/R&D Officer 57 31/05/2023
Director TitleAgeSince
Chairman 63 31/12/2012
Director/Board Member 65 31/12/2011
Director/Board Member 71 31/12/2011
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Exercice

Executive/Senior Manager

3,756 0.0007%
07/08/26 Free

Director

85 0.0000%
07/08/26 Free

Controller/Auditor

730 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%+1.56%+56.36%+74.73% 239B
-0.34%-1.73%+56.65%+107.06% 1,034B
+1.04%+4.68%+56.29%+73.14% 663B
-0.38%+1.11%+23.20%+78.66% 462B
+2.09%-2.06%+32.28%+38.37% 344B
0.00%+5.36%+27.40%+47.50% 307B
+1.42%+0.26%-0.52%+13.62% 251B
-0.03%+2.13%-17.30%-53.99% 207B
+0.52%+0.80%+32.80%+99.65% 186B
-1.09%+2.25%+15.57%-19.02% 165B
Average +0.46%-0.37%+28.27%+45.97% 385.88B
Weighted average by Cap. +0.42%-0.69%+37.47%+64.49%

Financials

2026 *2027 *
Net sales 38.94B 33.51B 31.44B 28.77B 53.7B 3,681B 54.12B 372B 145B 1,881B 146B 143B 6,059B 40.24B 34.62B 32.49B 29.73B 55.49B 3,804B 55.92B 384B 150B 1,944B 151B 148B 6,261B
Net income 8.6B 7.4B 6.94B 6.35B 11.85B 813B 11.95B 82.12B 31.98B 415B 32.29B 31.58B 1,338B 9.39B 8.08B 7.58B 6.94B 12.95B 888B 13.05B 89.72B 34.94B 454B 35.28B 34.51B 1,462B
Net Debt 41.69B 35.87B 33.66B 30.8B 57.48B 3,941B 57.94B 398B 155B 2,014B 157B 153B 6,486B 36.3B 31.23B 29.31B 26.81B 50.05B 3,431B 50.44B 347B 135B 1,754B 136B 133B 5,647B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
03/09/26 US$443.42 +0.13% 399,889
02/09/26 US$442.84 +1.08% 2,286,291
01/09/26 US$438.12 +1.92% 2,359,102
31/08/26 US$429.88 -0.59% 2,343,377
28/08/26 US$432.42 -1.05% 1,739,954
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
442.84USD
Average target price
388.48USD
Spread / Average Target
-12.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock